T cells and CD45R expression in B-chronic lymphocytic leukemia

Area of Science:

• Immunology
• Hematology
• Oncology

Background:

• B cell chronic lymphocytic leukemia (B-CLL) is characterized by significant secondary immunodeficiency affecting both humoral and cellular immunity.
• Previous studies noted T cell subset redistributions in B-CLL, but the underlying mechanisms remain largely unexplained.

Purpose of the Study:

• To investigate the immunophenotype of T cells in B-CLL by assessing CD45R expression.
• To explore relationships between T cell subsets, disease progression, and immune dysfunction in B-CLL.

Main Methods:

• Employed a two-colour immunofluorescence technique to analyze CD45R expression on T cell subsets (CD3+, CD4+, CD8+).
• Correlated T cell subset counts with total leukocyte counts and clinical disease stage.

Main Results:

• Significantly higher proportions of CD45R+ cells were observed among CD3+, CD4+, and CD8+ T cells in B-CLL patients compared to normal controls (p < 0.001).
• Strong positive correlations were found between total leukocyte count and the numbers of CD3+, CD4+, CD8+ cells, and monocytes in B-CLL.
• Patients with more advanced disease showed higher numbers of CD3+ and CD4+ T cells (p < 0.05).

Conclusions:

• An excess of CD45R+ suppressor-inducer T cells is a key feature of B-CLL.
• This T cell abnormality has significant implications for both B and T cell dysfunction observed in B-CLL.
• The findings suggest a role for CD45R+ T cells in the progression of B-CLL.